Positive Marijuana Research Database
Medical cannabis (marijuana) users frequently use it to reduce pain and prescription use. What are some motivators for those who consume under the legally renewed adult use or “recreational” option? Between August and October of 2016, 1000 non-medical cannabis users who voluntarily participated in a survey at two Colorado dispensaries provided some insights. 65% reported […]
A 21 month observation period of 37 habitual opioid using chronic pain patients who were enrolled in the New Mexico medical cannabis program was performed and they were compared to 29 non-enrolled patients. This 21 month period included 3 months prior to beginning cannabis treatment, and focused on opioid prescription activity in order to measure […]
MMJ is the abbreviation for medical marijuana, which is the medical utilization of the naturally occurring whole cannabis plant for therapeutic purposes, the most common of which is the reduction of pain. As more individuals partake of this natural plant in a medicinal fashion, opportunities continue to arise which allow new studies of its effects, […]
While the active ingredient of cannabis (marijuana) known as THC is considered to be a potential treatment for Alzheimer’s disease, this study sought to determine the safety and effectiveness of medical cannabis oil containing THC as an addition to other pharmacologicals. Specifically, they sought to evaluate it’s effect on alleviating behavioral and psychological symptoms of […]
Parkinson’s disease is typically associated with both tremor and bradykinesia (slowness of motion). This open-label observational study set out to determine the effect of cannabis (marijuana) on both motor and non-motor symptoms of Parkinson’s disease (PD). Twenty-two patients attending a motor disorder clinic in 2011-2012 were evaluated at a baseline and again 30 minutes following […]
Current medications generally only provide partial relief for sufferers of post traumatic stress disorder (PTSD), and those who don’t fully respond have a high rate of substance abuse. Marijuana (cannabis) is often used as an additional “compassion” therapy for those not fully responding to typical medicines. In this small pilot study, 10 medication stable patients […]
The theory of clinical endocannabinoid deficiency was published in 2001. It was based on the concept that many brain disorders are associated with neurotransmitter deficiencies, and that a similar scenario could be at play in the endocannabinoid system, which would then manifest as certain disorders. The endocannabinoid system was named after the cannabis (marijuana) plant, […]
Previous studies have demonstrated that opioid deaths have reduced in states that have legalized medical cannabis (marijuana). One explanation is that patients simply substitute marijuana for opioids. This study evaluated whether substituting marijuana was true for other psychoactive medications. 1,513 dispensary members in New England completed an online survey regarding their marijuana usage and substitution […]
Not all medical marijuana (cannabis) programs do this, but Minnesota’s program is unique because it collects patient-reported scores on symptoms. Read further to find out about improvement in symptom severity for patients with cancer during their first 4 months in this program. Patients in the program reported their symptoms (anxiety, lack of appetite, depression, disturbed […]
This study may very well represent the first neuroimaging investigation of patients using marijuana for medical purposes, and the results are both astounding and exciting! This is distinctly different from past evidence regarding recreational use showing potential cognitive deficits. The difference between medical and recreational use will be described further in a moment. At the […]